MedKoo Cat#: 563569 | Name: BAY32-5915
Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

BAY32-5915 is an IKKalpha inhibitor.

Chemical Structure

BAY32-5915
BAY32-5915
CAS#1571-30-8

Theoretical Analysis

MedKoo Cat#: 563569

Name: BAY32-5915

CAS#: 1571-30-8

Chemical Formula: C10H7NO3

Exact Mass: 189.0426

Molecular Weight: 189.17

Elemental Analysis: C, 63.49; H, 3.73; N, 7.40; O, 25.37

Price and Availability

Size Price Availability Quantity
1g USD 250.00 2 Weeks
5g USD 650.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
BAY32-5915; BAY32 5915; BAY325915; BAY 32 5915; BAY-32-5915; BAY 32-5915;
IUPAC/Chemical Name
8-Hydroxyquinoline-2-carboxylic acid
InChi Key
UHBIKXOBLZWFKM-UHFFFAOYSA-N
InChi Code
InChI=1S/C10H7NO3/c12-8-3-1-2-6-4-5-7(10(13)14)11-9(6)8/h1-5,12H,(H,13,14)
SMILES Code
O=C(C1=NC2=C(O)C=CC=C2C=C1)O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 189.17 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Pletz N, Schön M, Ziegelbauer K, Emmert S, Liu N, Dobbelstein M, Schön MP. Doxorubicin-induced activation of NF-κB in melanoma cells is abrogated by inhibition of IKKβ, but not by a novel IKKα inhibitor. Exp Dermatol. 2012 Apr;21(4):301-4. doi: 10.1111/j.1600-0625.2012.01440.x. Epub 2012 Feb 10. PubMed PMID: 22320445.